Zobair M Younossi (Zobair Younossi)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 36

Top Topics

Alcohol Consumption

African American

Cardiovascular Risk Factors

Top Venues

Hepatology communications

Hepatology (Baltimore, Md.)

The American journal of gastroenterology

Clinical and translational gastroenterology

This page only lists publications with an associated author ORCID identifier.

Publications

Zobair M Younossi, Kamal Kant Mangla, Tina Landsvig Berentzen, Katrine Grau, Mette Skalshøi Kjaer, Steen Ladelund, Louise Maymann Nitze, Crystal Coolbaugh, Chih-Yuan Hsu, Hannes Hagström
Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (6) (2024)
Zobair M Younossi, Kamal Kant Mangla, Abhishek Shankar Chandramouli, Jeffrey Victor Lazarus
Estimating the economic impact of comorbidities in patients with MASH and defining high-cost burden in patients with noncirrhotic MASH. Hepatology communications 8 (8) (2024)
James M Paik, Sandy Duong, Shira Zelber-Sagi, Jeffrey Victor Lazarus, Linda Henry, Zobair M Younossi
Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents in the United States. The American journal of gastroenterology 119 (6) (2024)
Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila
Development of a Primary Biliary Cholangitis-specific Version of Chronic Liver Disease Questionnaire: CLDQ-PBC. Clinical and translational gastroenterology (2024)
Zobair M Younossi, Kamal Kant Mangla, Tina Landsvig Berentzen, Katrine Grau, Mette Skalshøi Kjaer, Steen Ladelund, Louise Maymann Nitze, Crystal Coolbaugh, Chih-Yuan Hsu, Hannes Hagström
Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (6) (2024)
Zobair M Younossi, Kamal Kant Mangla, Tina Landsvig Berentzen, Katrine Grau, Mette Skalshøi Kjaer, Steen Ladelund, Louise Maymann Nitze, Crystal Coolbaugh, Chih-Yuan Hsu, Hannes Hagström
Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (6) (2024)
Zobair M Younossi, Kamal Kant Mangla, Tina Landsvig Berentzen, Katrine Grau, Mette Skalshøi Kjaer, Steen Ladelund, Louise Maymann Nitze, Crystal Coolbaugh, Chih-Yuan Hsu, Hannes Hagström
Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis. Hepatology communications 8 (6) (2024)
James M Paik, Sandy Duong, Shira Zelber-Sagi, Jeffrey Victor Lazarus, Linda Henry, Zobair M Younossi
Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents in the United States. The American journal of gastroenterology 119 (6) (2024)
James M Paik, Sandy Duong, Shira Zelber-Sagi, Jeffrey Victor Lazarus, Linda Henry, Zobair M Younossi
Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents in the United States. The American journal of gastroenterology (2024)
Zobair M Younossi, Kamal Kant Mangla, Abhishek Shankar Chandramouli, Jeffrey Victor Lazarus
Estimating the economic impact of comorbidities in patients with MASH and defining high-cost burden in patients with noncirrhotic MASH. Hepatology communications 8 (8) (2024)
James M Paik, Sandy Duong, Shira Zelber-Sagi, Jeffrey Victor Lazarus, Linda Henry, Zobair M Younossi
Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents in the United States. The American journal of gastroenterology 119 (6) (2024)
Zobair M Younossi, Kamal Kant Mangla, Abhishek Shankar Chandramouli, Jeffrey Victor Lazarus
Estimating the economic impact of comorbidities in patients with MASH and defining high-cost burden in patients with noncirrhotic MASH. Hepatology communications 8 (8) (2024)
Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila
Validation of a Primary Biliary Cholangitis-Specific Version of Chronic Liver Disease Questionnaire: CLDQ-PBC. Clinical and translational gastroenterology (2024)
James M Paik, Sandy Duong, Shira Zelber-Sagi, Jeffrey Victor Lazarus, Linda Henry, Zobair M Younossi
Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction Associated Fatty Liver Disease (MASLD) Among Adolescents in the United States. The American journal of gastroenterology (2024)
Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila
Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC. Hepatology communications 7 (2) (2023)
Zobair M Younossi, Maria Stepanova, Reem Al Shabeeb, Katherine E Eberly, Dipam Shah, Veronica Nguyen, Janus Ong, Linda Henry, Saleh A Alqahtani
The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease. Hepatology communications 8 (1) (2023)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Kenneth Cusi, Zobair M Younossi, Michael Roden
From NAFLD to MASLD: Promise and pitfalls of a new definition †. Hepatology (Baltimore, Md.) 79 (2) (2023)
Zobair M Younossi, Pegah Golabi, James M Paik, Austin Henry, Catherine Van Dongen, Linda Henry
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore, Md.) 77 (4) (2023)
Zobair M Younossi, Maria Stepanova, Reem Al Shabeeb, Katherine E Eberly, Dipam Shah, Veronica Nguyen, Janus Ong, Linda Henry, Saleh A Alqahtani
The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease. Hepatology communications 8 (1) (2023)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Zobair M Younossi, Pegah Golabi, James M Paik, Austin Henry, Catherine Van Dongen, Linda Henry
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore, Md.) 77 (4) (2023)
Kenneth Cusi, Zobair M Younossi, Michael Roden
From NAFLD to MASLD: Promise and pitfalls of a new definition †. Hepatology (Baltimore, Md.) 79 (2) (2023)
Kenneth Cusi, Zobair M Younossi, Michael Roden
From NAFLD to MASLD: Promise and pitfalls of a new definition†. Hepatology (Baltimore, Md.) (2023)
Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila
Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC. Hepatology communications 7 (2) (2023)
Zobair M Younossi, Pegah Golabi, James M Paik, Austin Henry, Catherine Van Dongen, Linda Henry
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore, Md.) (2023)
Kenneth Cusi, Zobair M Younossi, Michael Roden
From NAFLD to MASLD: Promise and pitfalls of a new definition †. Hepatology (Baltimore, Md.) 79 (2) (2023)
Zobair M Younossi, Maria Stepanova, Reem Al Shabeeb, Katherine E Eberly, Dipam Shah, Veronica Nguyen, Janus Ong, Linda Henry, Saleh A Alqahtani
The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease. Hepatology communications 8 (1) (2023)
Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila
Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC. Hepatology communications 7 (2) (2023)
Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila
Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC. Hepatology communications 7 (2) (2023)
Zobair M Younossi, Pegah Golabi, James M Paik, Austin Henry, Catherine Van Dongen, Linda Henry
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore, Md.) 77 (4) (2023)
Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila
Development and validation of a primary sclerosing cholangitis-specific health-related quality of life instrument: CLDQ-PSC. Hepatology communications 7 (2) (2023)
Zobair M Younossi, Pegah Golabi, James M Paik, Austin Henry, Catherine Van Dongen, Linda Henry
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore, Md.) 77 (4) (2023)
Arun J Sanyal, Stephen Caldwell, Quentin Mark Anstee, Vlad Ratziu, Kris V Kowdley, Mary E Rinella, Stephen A Harrison, Murray B Resnick, Thomas Capozza, Sangeeta Sawhney, Nirav Shelat, Zobair M Younossi
Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study. Hepatology communications 8 (1) (2023)
Kenneth Cusi, Zobair M Younossi, Michael Roden
From NAFLD to MASLD: Promise and pitfalls of a new definition †. Hepatology (Baltimore, Md.) 79 (2) (2023)
Zobair M Younossi, Pegah Golabi, James M Paik, Austin Henry, Catherine Van Dongen, Linda Henry
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore, Md.) (2023)